SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-037624
Filing Date
2022-11-14
Accepted
2022-11-14 16:15:11
Documents
13
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mtcr-8k_20221114.htm   iXBRL 8-K 39521
2 EX-99.1 mtcr-ex991_6.htm EX-99.1 166362
  Complete submission text file 0001564590-22-037624.txt   347832

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20221114.xsd EX-101.SCH 5593
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20221114_lab.xml EX-101.LAB 20067
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20221114_pre.xml EX-101.PRE 11941
7 EXTRACTED XBRL INSTANCE DOCUMENT mtcr-8k_20221114_htm.xml XML 3673
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39512 | Film No.: 221385536
SIC: 2834 Pharmaceutical Preparations